HIGHLIGHTS
- who: Sardar Sindhu from the (UNIVERSITY) have published the Article: Increased circulatory levels of fractalkine (CX3CL1) are associated with inflammatory chemokines and cytokines in individuals with type-2 diabetes, in the Journal: (JOURNAL)
- what: The authors report significantly higher plasma fractalkine levels in T2D patients as compared with non-diabetic individuals.
- how: The data were compared using unpaired t-test and the dependence between two variables was assessed by Pearson's correlation coefficient (r).
- future: These correlative data support the fractalkine as a marker for metabolic inflammation in T2D patients nonetheless . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.